Together, heart failure and arrhythmia represent the most important cardiovascular sources of morbidity and mortality among adults with congenital heart disease (ACHDs). Although traditionally conceptualized as operating within 2 distinct clinical silos, these scenarios frequently coexist within the same individual; consequently the mechanistic, therapeutic, and prognostic overlap between them demands increased recognition. In fact, given the near ubiquity of heart failure and arrhythmia among ACHDs, there is perhaps no other arena within cardiology where this critical intersection is more frequently observed. Optimal care for ACHDs therefore requires a heightened awareness of the relevant interactions as well as the pharmacologic and interventional resources that are increasingly available to the treating cardiologist. This review explores and highlights the overlap between these 2 fields to recommend a parallel, yet interactive, multidisciplinary approach to clinical management. Congenital heart disease categories are broken down into their archetypal subtypes to highlight subtleties of the pathophysiology, evaluation, and therapeutic approach.
Editors
Editor-in-Chief
Valentin Fuster, MD, PhD, MACC
CME Editor
Ragavendra R. Baliga, MD
Authors
Jeremy P. Moore, MD, MS
Mitchell I. Cohen, MD
Jonathan N. Menachem, MD
David S. Frankel, MD
Lucy Roche, MBCHB
Ali N. Zaidi, MD
Robert H. Pass, MD
Ari M. Cedars, MD
Important Dates
Date of Release: November 28, 2022
Term of Approval/Date of CME/MOC/ECME Expiration: November 27, 2023